Michael Otto - Publications

Affiliations: 
Department of Psychology Boston University, Boston, MA, United States 
Area:
Clinical Psychology

265 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Fitzgerald HE, Gorlin EI, Otto MW. Working memory moderates the predictive influence of distress intolerance on health-related goal attainment. Cognitive Behaviour Therapy. 1-6. PMID 33021156 DOI: 10.1080/16506073.2020.1819864  0.44
2020 Stathopoulou G, Gold AK, Hoyt DL, Milligan M, Hearon BA, Otto MW. Does anxiety sensitivity predict addiction severity in opioid use disorder? Addictive Behaviors. 112: 106644. PMID 32987306 DOI: 10.1016/j.addbeh.2020.106644  0.96
2020 Otto MW, Zvolensky MJ, Rosenfield D, Hoyt DL, Witkiewitz K, McKee SA, Bickel WK, Smits JAJ. A randomized controlled trial protocol for engaging distress tolerance and working memory to aid smoking cessation in low socioeconomic status (SES) adults. Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association. 39: 815-825. PMID 32833483 DOI: 10.1037/hea0000858  0.92
2020 Carl JR, Miller CB, Henry AL, Davis ML, Stott R, Smits JAJ, Emsley R, Gu J, Shin O, Otto MW, Craske MG, Saunders KEA, Goodwin GM, Espie CA. Efficacy of digital cognitive behavioral therapy for moderate-to-severe symptoms of generalized anxiety disorder: A randomized controlled trial. Depression and Anxiety. PMID 32725848 DOI: 10.1002/da.23079  0.92
2020 Hoyt DL, Kinsler BE, Otto MW, Garey L, Mayorga NA, Zvolensky MJ. An investigation of racial and ethnic differences in e-cigarette beliefs and use characteristics. Journal of Ethnicity in Substance Abuse. 1-15. PMID 32543305 DOI: 10.1080/15332640.2020.1777607  0.92
2020 Smits JAJ, Pollack MH, Rosenfield D, Otto MW, Dowd S, Carpenter J, Dutcher CD, Lewis EM, Witcraft SM, Papini S, Curtiss J, Andrews L, Kind S, Conroy K, Hofmann SG. Dose Timing of D-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder: A Randomized Clinical Trial. Jama Network Open. 3: e206777. PMID 32496566 DOI: 10.1001/jamanetworkopen.2020.6777  0.96
2020 Conroy HE, Jacquart J, Baird SO, Rosenfield D, Davis ML, Powers MB, Frierson GM, Marcus BH, Otto MW, Zvolensky MJ, Smits JAJ. Age and pre quit-day attrition during smoking cessation treatment. Cognitive Behaviour Therapy. 1-13. PMID 32343190 DOI: 10.1080/16506073.2020.1751262  0.92
2020 Papini S, Young CC, Gebhardt CS, Perrone A, Morikawa H, Otto MW, Roache JD, Smits JAJ. Isradipine enhancement of virtual reality cue exposure for smoking cessation: Rationale and study protocol for a double-blind randomized controlled trial. Contemporary Clinical Trials. 106013. PMID 32335287 DOI: 10.1016/j.cct.2020.106013  0.92
2020 Gold AK, Otto MW, Sylvia LG. Bipolar disorder as a condition of heterogeneity: Embracing an adaptive psychosocial approach. Bipolar Disorders. PMID 32145140 DOI: 10.1111/bdi.12896  0.72
2020 Szuhany KL, Otto MW. Assessing BDNF as a mediator of the effects of exercise on depression. Journal of Psychiatric Research. 123: 114-118. PMID 32065946 DOI: 10.1016/j.jpsychires.2020.02.003  0.56
2020 Smits JAJ, Zvolensky MJ, Otto MW, Piper ME, Baird SO, Kauffman BY, Lee-Furman E, Alavi N, Dutcher CD, Papini S, Rosenfield B, Rosenfield D. Enhancing panic and smoking reduction treatment with D-Cycloserine: A pilot randomized clinical trial. Drug and Alcohol Dependence. 208: 107877. PMID 32004998 DOI: 10.1016/j.drugalcdep.2020.107877  0.92
2019 Otto MW, Rosenfield D, Gorlin EI, Hoyt DL, Patten EA, Bickel WK, Zvolensky MJ, Doan SN. Targeting cognitive and emotional regulatory skills for smoking prevention in low-SES youth: A randomized trial of mindfulness and working memory interventions. Addictive Behaviors. 104: 106262. PMID 31918169 DOI: 10.1016/j.addbeh.2019.106262  0.92
2019 Szuhany KL, Otto MW. The new TV dinner: effects of television programming content on eating and attitudes towards exercise. Psychology, Health & Medicine. 1-6. PMID 31847572 DOI: 10.1080/13548506.2019.1705990  0.56
2019 Rosenfield D, Smits JAJ, Hofmann SG, Mataix-Cols D, de la Cruz LF, Andersson E, Rück C, Monzani B, Pérez-Vigil A, Frumento P, Davis M, de Kleine RA, Difede J, Dunlop BW, Farrell LJ, ... ... Otto MW, et al. Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis. Journal of Anxiety Disorders. 68: 102149. PMID 31698111 DOI: 10.1016/j.janxdis.2019.102149  0.96
2019 Patten EA, Kredlow MA, Szuhany KL, Keshishian AC, Otto MW. Catching As and Zs: poor sleep quality predicts failures to increase studying time. Sleep Health. PMID 31676201 DOI: 10.1016/j.sleh.2019.09.001  0.6
2019 Hofmann SG, Papini S, Carpenter JK, Otto MW, Rosenfield D, Dutcher CD, Dowd S, Lewis M, Witcraft S, Pollack MH, Smits JAJ. Effect of d-cycloserine on fear extinction training in adults with social anxiety disorder. Plos One. 14: e0223729. PMID 31622374 DOI: 10.1371/journal.pone.0223729  0.96
2019 Kredlow MA, Keshishian A, Oppenheimer S, Otto MW. The Efficacy of Modafinil as a Cognitive Enhancer: A Systematic Review and Meta-Analysis. Journal of Clinical Psychopharmacology. PMID 31433334 DOI: 10.1097/JCP.0000000000001085  0.6
2019 Garey L, Smit T, Mayorga NA, Peraza N, Nizio P, Otto MW, Zvolensky MJ. Differential Effects of Anxiety Sensitivity on E-Cigarettes Processes: The Importance of E-Cigarette Quit Attempt History. The American Journal On Addictions. PMID 31381212 DOI: 10.1111/ajad.12940  0.92
2019 Mayorga NA, Chavez J, Garey L, Otto MW, Zvolensky MJ. Affective Vulnerability across Non-Daily and Daily Electronic Cigarette Users. Behavioral Medicine (Washington, D.C.). 1-9. PMID 31361573 DOI: 10.1080/08964289.2019.1644282  0.92
2019 Szuhany KL, Otto MW. Efficacy evaluation of exercise as an augmentation strategy to brief behavioral activation treatment for depression: a randomized pilot trial. Cognitive Behaviour Therapy. 1-14. PMID 31357916 DOI: 10.1080/16506073.2019.1641145  0.56
2019 Garey L, Mayorga NA, Peraza N, Smit T, Nizio P, Otto MW, Zvolensky MJ. Distinguishing Characteristics of E-Cigarette Users Who Attempt and Fail to Quit: Dependence, Perceptions, and Affective Vulnerability. Journal of Studies On Alcohol and Drugs. 80: 134-140. PMID 30807286  0.92
2019 Gold AK, Stathopoulou G, Otto MW. Emotion regulation and motives for illicit drug use in opioid-dependent patients. Cognitive Behaviour Therapy. 1-7. PMID 30760111 DOI: 10.1080/16506073.2019.1579256  0.72
2018 Otto MW, Smits JAJ. Anxiety Sensitivity, Health Behaviors, and the Prevention and Treatment of Medical Illness. Clinical Psychology : a Publication of the Division of Clinical Psychology of the American Psychological Association. 25. PMID 30686865 DOI: 10.1111/cpsp.12253  0.92
2018 Stein AT, Medina JL, Rosenfield D, Otto MW, Smits JAJ. Examining experiential avoidance as a mediator of the relation between anxiety sensitivity and depressive symptoms. Cognitive Behaviour Therapy. 1-14. PMID 30507350 DOI: 10.1080/16506073.2018.1546768  0.92
2018 Otto MW, Pachas GN, Cather C, Hoeppner SS, Moshier SJ, Hearon BA, Ward HB, Laffer AB, Smits JAJ, Evins AE. A placebo-controlled randomized trial of D-cycloserine augmentation of cue exposure therapy for smoking cessation. Cognitive Behaviour Therapy. 1-12. PMID 30111253 DOI: 10.1080/16506073.2018.1476908  0.96
2018 Gold AK, Peters AT, Otto MW, Sylvia LG, Magalhaes PVDS, Berk M, Dougherty DD, Miklowitz DJ, Frank E, Nierenberg AA, Deckersbach T. The impact of substance use disorders on recovery from bipolar depression: Results from the Systematic Treatment Enhancement Program for Bipolar Disorder psychosocial treatment trial. The Australian and New Zealand Journal of Psychiatry. 4867418788172. PMID 30047784 DOI: 10.1177/0004867418788172  0.72
2018 Kredlow MA, Orr SP, Otto MW. Exploring the boundaries of post-retrieval extinction in healthy and anxious individuals. Behaviour Research and Therapy. 108: 45-57. PMID 29981938 DOI: 10.1016/j.brat.2018.06.010  0.6
2018 Zvolensky MJ, Rosenfield D, Garey L, Kauffman BY, Langdon KJ, Powers MB, Otto MW, Davis ML, Marcus BH, Church TS, Frierson GM, Hopkins LB, Paulus DJ, Baird SO, Smits JAJ. Does exercise aid smoking cessation through reductions in anxiety sensitivity and dysphoria? Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association. PMID 29708388 DOI: 10.1037/hea0000588  0.92
2018 Otto MW, Gorlin EI, Rosenfield D, Patten EA, Bickel WK, Zvolensky MJ, Doan SN. Rescuing cognitive and emotional regulatory skills to aid smoking prevention in at-risk youth: A randomized trial. Contemporary Clinical Trials. PMID 29655859 DOI: 10.1016/j.cct.2018.04.005  0.92
2018 Stathopoulou G, Pollack MH, Otto MW. Anxiety sensitivity moderates drug cravings in response to induced negative affect in opioid dependent outpatients. Addictive Behaviors. 84: 75-78. PMID 29631093 DOI: 10.1016/j.addbeh.2018.03.020  0.8
2018 Gold AK, Otto MW, Deckersbach T, Sylvia LG, Nierenberg AA, Kinrys G. Substance use comorbidity in bipolar disorder: A qualitative review of treatment strategies and outcomes. The American Journal On Addictions. 27: 188-201. PMID 29596721 DOI: 10.1111/ajad.12713  0.72
2018 Szuhany KL, MacKenzie D, Otto MW. The impact of depressed mood, working memory capacity, and priming on delay discounting. Journal of Behavior Therapy and Experimental Psychiatry. 60: 37-41. PMID 29547848 DOI: 10.1016/j.jbtep.2018.03.001  0.56
2018 Kredlow MA, Eichenbaum H, Otto MW. Memory creation and modification: Enhancing the treatment of psychological disorders. The American Psychologist. PMID 29494172 DOI: 10.1037/amp0000185  0.6
2017 Deckersbach T, Peters AT, Shea C, Gosai A, Stange JP, Peckham AD, Ellard KK, Otto MW, Rauch SL, Dougherty DD, Nierenberg AA. Memory performance predicts response to psychotherapy for depression in bipolar disorder: A pilot randomized controlled trial with exploratory functional magnetic resonance imaging. Journal of Affective Disorders. 229: 342-350. PMID 29331692 DOI: 10.1016/j.jad.2017.12.041  0.88
2017 Roque AD, Rosenfield D, Smits JAJ, Simon N, Otto MW, Marques L, Pollack MH, Hofmann SG, Meuret AE. Does d-cycloserine facilitate the effects of homework compliance on social anxiety symptom reduction? Journal of Anxiety Disorders. 53: 85-90. PMID 29227845 DOI: 10.1016/j.janxdis.2017.11.004  0.96
2017 Gorlin EI, Lee J, Otto MW. A topographical map approach to representing treatment efficacy: a focus on positive psychology interventions. Cognitive Behaviour Therapy. 1-9. PMID 28758545 DOI: 10.1080/16506073.2017.1342173  0.44
2017 Yuan H, Mischoulon D, Fava M, Otto MW. Circulating microRNAs as biomarkers for depression: Many candidates, few finalists. Journal of Affective Disorders. PMID 28673667 DOI: 10.1016/j.jad.2017.06.058  0.44
2017 Kauffman BY, Garey L, Jardin C, Otto MW, Raines AM, Schmidt NB, Zvolensky MJ. Body Mass Index and functional impairment: the explanatory role of anxiety sensitivity among treatment-seeking smokers. Psychology, Health & Medicine. 1-12. PMID 28651434 DOI: 10.1080/13548506.2017.1344357  0.92
2017 Jacquart J, Papini S, Davis ML, Rosenfield D, Powers MB, Frierson GM, Hopkins LB, Baird SO, Marcus BH, Church TS, Otto MW, Zvolensky MJ, Smits JA. Identifying attendance patterns in a smoking cessation treatment and their relationships with quit success. Drug and Alcohol Dependence. 174: 65-69. PMID 28315809 DOI: 10.1016/j.drugalcdep.2017.01.007  0.92
2017 Mataix-Cols D, Fernández de la Cruz L, Monzani B, Rosenfield D, Andersson E, Pérez-Vigil A, Frumento P, de Kleine RA, Difede J, Dunlop BW, Farrell LJ, Geller D, Gerardi M, Guastella AJ, Hofmann SG, ... ... Otto MW, et al. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis. Jama Psychiatry. PMID 28122091 DOI: 10.1001/jamapsychiatry.2016.3955  0.96
2017 Moshier SJ, Otto MW. Behavioral activation treatment for major depression: A randomized trial of the efficacy of augmentation with cognitive control training. Journal of Affective Disorders. 210: 265-268. PMID 28068613 DOI: 10.1016/j.jad.2017.01.003  0.56
2016 Hearon BA, Beard C, Kopeski LM, Smits JA, Otto MW, Björgvinsson T. Attending to Timely Contingencies: Promoting Physical Activity Uptake Among Adults with Serious Mental Illness with an Exercise-For-Mood vs. an Exercise-For-Fitness Prescription. Behavioral Medicine (Washington, D.C.). 0. PMID 28027010 DOI: 10.1080/08964289.2016.1276428  0.96
2016 Farris SG, Davis ML, Rosenfield D, Kauffman BY, Baird SO, Powers MB, Otto MW, Marcus BH, Church TS, Smits JA, Zvolensky MJ. Exercise Self-Efficacy Moderates the Relation between Anxiety Sensitivity and Body Mass Index and Exercise Tolerance in Treatment-Seeking Smokers. Mental Health and Physical Activity. 10: 25-32. PMID 27725844 DOI: 10.1016/j.mhpa.2016.05.001  0.92
2016 Powers MB, Davis ML, Kauffman BY, Baird SO, Zvolensky M, Rosenfield D, Marcus BH, Church TS, Frierson G, Otto MW, Smits JA. Anxiety sensitivity and smoking variability among treatment seeking smokers. Addictive Disorders & Their Treatment. 15: 136-142. PMID 27672353 DOI: 10.1097/ADT.0000000000000075  0.92
2016 Sylvia LG, Salcedo S, Peters AT, Magalhães PV, Frank E, Miklowitz DJ, Otto MW, Berk M, Nierenberg AA, Deckersbach T. Do Sleep Disturbances Predict or Moderate the Response to Psychotherapy in Bipolar Disorder? The Journal of Nervous and Mental Disease. PMID 27660995 DOI: 10.1097/NMD.0000000000000579  0.92
2016 Otto MW, Eastman A, Lo S, Hearon BA, Bickel WK, Zvolensky M, Smits JA, Doan SN. Anxiety sensitivity and working memory capacity: Risk factors and targets for health behavior promotion. Clinical Psychology Review. 49: 67-78. PMID 27611632 DOI: 10.1016/j.cpr.2016.07.003  0.96
2016 Smits JA, Powers MB, Rosenfield D, Zvolensky MJ, Jacquart J, Davis ML, Beevers CG, Marcus BH, Church TS, Otto MW. BDNF Val66Met Polymorphism as a Moderator of Exercise Enhancement of Smoking Cessation Treatment in Anxiety Vulnerable Adults. Mental Health and Physical Activity. 10: 73-77. PMID 27453731 DOI: 10.1016/j.mhpa.2016.01.001  0.92
2016 Yamada T, Moshier SJ, Otto MW. No site unseen: predicting the failure to control problematic Internet use among young adults. Cognitive Behaviour Therapy. 1-5. PMID 27426432 DOI: 10.1080/16506073.2016.1205657  0.56
2016 Otto MW, Pollack MH, Dowd SM, Hofmann SG, Pearlson G, Szuhany KL, Gueorguieva R, Krystal JH, Simon NM, Tolin DF. RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER. Depression and Anxiety. PMID 27315514 DOI: 10.1002/da.22531  0.96
2016 Baldwin AS, Kangas JL, Denman DC, Smits JA, Yamada T, Otto MW. Cardiorespiratory fitness moderates the effect of an affect-guided physical activity prescription: a pilot randomized controlled trial. Cognitive Behaviour Therapy. 1-13. PMID 27310568 DOI: 10.1080/16506073.2016.1194454  0.92
2016 Deckersbach T, Peters AT, Sylvia LG, Gold AK, da Silva Magalhaes PV, Henry DB, Frank E, Otto MW, Berk M, Dougherty DD, Nierenberg AA, Miklowitz DJ. A cluster analytic approach to identifying predictors and moderators of psychosocial treatment for bipolar depression: Results from STEP-BD. Journal of Affective Disorders. 203: 152-157. PMID 27289316 DOI: 10.1016/j.jad.2016.03.064  0.92
2016 Otto MW, Lee J, Hofmann SG, Hearon BA, Smits JA, Rosenfield D, Fava M, Wright JH. Examining the Efficacy of D-cycloserine to Augment Therapeutic Learning in Depression. Contemporary Clinical Trials. PMID 27094721 DOI: 10.1016/j.cct.2016.03.009  0.92
2016 Meuret AE, Chmielewski M, Steele AM, Rosenfield D, Petersen S, Smits JA, Simon NM, Otto MW, Marques L, Pollack MH, Hofmann SG. The desire to belong: Social identification as a predictor of treatment outcome in social anxiety disorder. Behaviour Research and Therapy. 81: 21-34. PMID 27070526 DOI: 10.1016/j.brat.2016.03.008  0.92
2016 Smits JA, Kauffman BY, Lee-Furman E, Zvolensky MJ, Otto MW, Piper ME, Powers MB, Rosenfield D. Enhancing panic and smoking reduction treatment with d-cycloserine: Study protocol for a randomized controlled trial. Contemporary Clinical Trials. PMID 27015966 DOI: 10.1016/j.cct.2016.03.011  0.92
2016 Fillo J, Alfano CA, Paulus DJ, Smits JA, Davis ML, Rosenfield D, Marcus BH, Church TS, Powers MB, Otto MW, Baird SO, Zvolensky MJ. Emotion dysregulation explains relations between sleep disturbance and smoking quit-related cognition and behavior. Addictive Behaviors. 57: 6-12. PMID 26827153 DOI: 10.1016/j.addbeh.2016.01.013  0.92
2016 Stange JP, Sylvia LG, da Silva Magalhães PV, Miklowitz DJ, Otto MW, Frank E, Yim C, Berk M, Dougherty DD, Nierenberg AA, Deckersbach T. Affective instability and the course of bipolar depression: results from the STEP-BD randomised controlled trial of psychosocial treatment. The British Journal of Psychiatry : the Journal of Mental Science. PMID 26795426 DOI: 10.1192/bjp.bp.114.162073  0.92
2016 Farris SG, Davis ML, Rosenfield D, Kauffman BY, Baird SO, Powers MB, Otto MW, Marcus BH, Church TS, Smits JAJ, Zvolensky MJ. Exercise self-efficacy moderates the relation between anxiety sensitivity and body mass index and exercise tolerance in treatment-seeking smokers Mental Health and Physical Activity. 10: 25-32. DOI: 10.1016/j.mhpa.2016.05.001  0.92
2015 Reynolds GO, Otto MW, Ellis TD, Cronin-Golomb A. The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26715466 DOI: 10.1002/mds.26484  0.6
2015 Kredlow MA, Unger LD, Otto MW. Harnessing Reconsolidation to Weaken Fear and Appetitive Memories: A Meta-Analysis of Post-Retrieval Extinction Effects. Psychological Bulletin. PMID 26689086 DOI: 10.1037/bul0000034  0.6
2015 Peters AT, Shesler LW, Sylvia L, da Silva Magalhaes PV, Miklowitz DJ, Otto MW, Frank E, Berk M, Dougherty DD, Nierenberg AA, Deckersbach T. Medical burden, body mass index and the outcome of psychosocial interventions for bipolar depression. The Australian and New Zealand Journal of Psychiatry. PMID 26590023 DOI: 10.1177/0004867415616694  0.92
2015 Otto MW, Kredlow MA, Smits JA, Hofmann SG, Tolin DF, de Kleine RA, van Minnen A, Evins AE, Pollack MH. Enhancement of Psychosocial Treatment With d-Cycloserine: Models, Moderators, and Future Directions. Biological Psychiatry. PMID 26520240 DOI: 10.1016/j.biopsych.2015.09.007  0.96
2015 Smits JA, Zvolensky MJ, Davis ML, Rosenfield D, Marcus BH, Church TS, Powers MB, Frierson GM, Otto MW, Hopkins LB, Brown RA, Baird SO. The Efficacy of Vigorous-Intensity Exercise as an Aid to Smoking Cessation in Adults With High Anxiety Sensitivity: A Randomized Controlled Trial. Psychosomatic Medicine. PMID 26513517 DOI: 10.1097/PSY.0000000000000264  0.92
2015 Freed RD, Tompson MC, Otto MW, Nierenberg AA, Henin A. A latent class analysis of parental bipolar disorder: Examining associations with offspring psychopathology. Psychiatry Research. PMID 26394919 DOI: 10.1016/j.psychres.2015.09.011  0.92
2015 Szuhany KL, Otto MW. Contextual Influences on Distress Intolerance: Priming Effects on Behavioral Persistence. Cognitive Therapy and Research. 39: 499-507. PMID 26366022 DOI: 10.1007/s10608-015-9672-x  0.56
2015 Stein AT, Greathouse LJ, Otto MW. Eating in response to exercise cues: Role of self-control fatigue, exercise habits, and eating restraint. Appetite. 96: 56-61. PMID 26363420 DOI: 10.1016/j.appet.2015.09.007  0.92
2015 Moshier SJ, Szuhany KL, Hearon BA, Smits JA, Otto MW. Anxiety Sensitivity Uniquely Predicts Exercise Behaviors in Young Adults Seeking to Increase Physical Activity. Behavior Modification. PMID 26342011 DOI: 10.1177/0145445515603704  0.96
2015 Hofmann SG, Carpenter JK, Otto MW, Rosenfield D, Smits JA, Pollack MH. Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale. Contemporary Clinical Trials. 43: 223-30. PMID 26111923 DOI: 10.1016/j.cct.2015.06.015  0.92
2015 Farris SG, Zvolensky MJ, Otto MW, Leyro TM. The role of distress intolerance for panic and nicotine withdrawal symptoms during a biological challenge. Journal of Psychopharmacology (Oxford, England). 29: 783-91. PMID 25762651 DOI: 10.1177/0269881115575536  0.92
2015 Kredlow MA, Capozzoli MC, Hearon BA, Calkins AW, Otto MW. The effects of physical activity on sleep: a meta-analytic review. Journal of Behavioral Medicine. 38: 427-49. PMID 25596964 DOI: 10.1007/s10865-015-9617-6  0.96
2015 Kredlow MA, Otto MW. Interference with the reconsolidation of trauma-related memories in adults. Depression and Anxiety. 32: 32-7. PMID 25585535 DOI: 10.1002/da.22343  0.6
2015 Freed RD, Tompson MC, Wang CH, Otto MW, Hirshfeld-Becker DR, Nierenberg AA, Henin A. Family functioning in the context of parental bipolar disorder: associations with offspring age, sex, and psychopathology. Journal of Family Psychology : Jfp : Journal of the Division of Family Psychology of the American Psychological Association (Division 43). 29: 108-18. PMID 25528073 DOI: 10.1037/fam0000048  0.92
2015 Szuhany KL, Bugatti M, Otto MW. A meta-analytic review of the effects of exercise on brain-derived neurotrophic factor. Journal of Psychiatric Research. 60: 56-64. PMID 25455510 DOI: 10.1016/j.jpsychires.2014.10.003  0.56
2015 Hofmann SG, Otto MW, Pollack MH, Smits JA. D-cycloserine augmentation of cognitive behavioral therapy for anxiety disorders: an update. Current Psychiatry Reports. 17: 532. PMID 25413638 DOI: 10.1007/s11920-014-0532-2  0.92
2015 Powers MB, Davis ML, Kauffman BY, Baird SO, Zvolensky M, Rosenfield D, Marcus BH, Church TS, Frierson G, Otto MW, Smits JAJ. Anxiety Sensitivity and Smoking Variability Among Treatment Seeking Smokers Addictive Disorders and Their Treatment. DOI: 10.1097/ADT.0000000000000075  0.92
2015 Smits JAJ, Powers MB, Rosenfield D, Zvolensky MJ, Jacquart J, Davis ML, Beevers CG, Marcus BH, Church TS, Otto MW. BDNF Val66Met polymorphism as a moderator of exercise enhancement of smoking cessation treatment in anxiety vulnerable adults Mental Health and Physical Activity. DOI: 10.1016/j.mhpa.2016.01.001  0.6
2014 Medina JL, DeBoer LB, Davis ML, Rosenfield D, Powers MB, Otto MW, Smits JA. Gender moderates the effect of exercise on anxiety sensitivity. Mental Health and Physical Activity. 7: 147-151. PMID 26617672 DOI: 10.1016/j.mhpa.2014.08.002  0.92
2014 Otto MW, Hearon BA, McHugh RK, Calkins AW, Pratt E, Murray HW, Safren SA, Pollack MH. A randomized, controlled trial of the efficacy of an interoceptive exposure-based CBT for treatment-refractory outpatients with opioid dependence. Journal of Psychoactive Drugs. 46: 402-11. PMID 25364993 DOI: 10.1080/02791072.2014.960110  0.92
2014 Moshier SJ, Landau AJ, Hearon BA, Stein AT, Greathouse L, Smits JA, Otto MW. The Development of a Novel Measure to Assess Motives for Compensatory Eating in Response to Exercise: The CEMQ. Behavioral Medicine (Washington, D.C.). 1-12. PMID 25148129 DOI: 10.1080/08964289.2014.955077  0.92
2014 Peters A, Sylvia LG, Magalhães PV, Miklowitz DJ, Frank E, Otto MW, Hansen NS, Dougherty DD, Berk M, Nierenberg AA, Deckersbach T. Age at onset, course of illness and response to psychotherapy in bipolar disorder: results from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Psychological Medicine. 44: 3455-67. PMID 25066366 DOI: 10.1017/S0033291714000804  0.92
2014 Otto MW, Moshier SJ, Kinner DG, Simon NM, Pollack MH, Orr SP. De novo fear conditioning across diagnostic groups in the affective disorders: evidence for learning impairments. Behavior Therapy. 45: 619-29. PMID 25022773 DOI: 10.1016/j.beth.2013.12.012  0.92
2014 Hearon BA, Quatromoni PA, Mascoop JL, Otto MW. The role of anxiety sensitivity in daily physical activity and eating behavior. Eating Behaviors. 15: 255-8. PMID 24854814 DOI: 10.1016/j.eatbeh.2014.03.007  0.92
2014 Freed RD, Tompson MC, Otto MW, Nierenberg AA, Hirshfeld-Becker D, Wang CH, Henin A. Early risk factors for psychopathology in offspring of parents with bipolar disorder: the role of obstetric complications and maternal comorbid anxiety. Depression and Anxiety. 31: 583-90. PMID 24643978 DOI: 10.1002/da.22254  0.92
2014 Calkins AW, McMorran KE, Siegle GJ, Otto MW. The Effects of Computerized Cognitive Control Training on Community Adults with Depressed Mood. Behavioural and Cognitive Psychotherapy. 1-12. PMID 24589123 DOI: 10.1017/S1352465814000046  0.92
2014 Smoller JW, Gallagher PJ, Duncan LE, McGrath LM, Haddad SA, Holmes AJ, Wolf AB, Hilker S, Block SR, Weill S, Young S, Choi EY, Rosenbaum JF, Biederman J, Faraone SV, ... ... Otto MW, et al. The human ortholog of acid-sensing ion channel gene ASIC1a is associated with panic disorder and amygdala structure and function. Biological Psychiatry. 76: 902-10. PMID 24529281 DOI: 10.1016/j.biopsych.2013.12.018  0.92
2014 Stange JP, Sylvia LG, da Silva Magalhães PV, Miklowitz DJ, Otto MW, Frank E, Berk M, Hansen NS, Dougherty DD, Nierenberg AA, Deckersbach T. Extreme attributions predict suicidal ideation and suicide attempts in bipolar disorder: prospective data from STEP-BD. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 13: 95-6. PMID 24497260 DOI: 10.1002/wps.20093  0.92
2014 Smits JA, Rosenfield D, Davis ML, Julian K, Handelsman PR, Otto MW, Tuerk P, Shiekh M, Rosenfield B, Hofmann SG, Powers MB. Yohimbine enhancement of exposure therapy for social anxiety disorder: a randomized controlled trial. Biological Psychiatry. 75: 840-6. PMID 24237691 DOI: 10.1016/j.biopsych.2013.10.008  0.92
2014 Deckersbach T, Peters AT, Sylvia L, Urdahl A, Magalhães PV, Otto MW, Frank E, Miklowitz DJ, Berk M, Kinrys G, Nierenberg A. Do comorbid anxiety disorders moderate the effects of psychotherapy for bipolar disorder? Results from STEP-BD. The American Journal of Psychiatry. 171: 178-86. PMID 24077657 DOI: 10.1176/appi.ajp.2013.13020225  0.92
2013 McHugh RK, Reynolds EK, Leyro TM, Otto MW. An Examination of the Association of Distress Intolerance and Emotion Regulation with Avoidance. Cognitive Therapy and Research. 37: 363-367. PMID 32773909 DOI: 10.1007/s10608-012-9463-6  1
2013 Zalta AK, Dowd S, Rosenfield D, Smits JA, Otto MW, Simon NM, Meuret AE, Marques L, Hofmann SG, Pollack MH. Sleep quality predicts treatment outcome in CBT for social anxiety disorder. Depression and Anxiety. 30: 1114-20. PMID 24038728 DOI: 10.1002/da.22170  0.92
2013 Smits JA, Hofmann SG, Rosenfield D, DeBoer LB, Costa PT, Simon NM, O'Cleirigh C, Meuret AE, Marques L, Otto MW, Pollack MH. D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: prognostic and prescriptive variables. Journal of Consulting and Clinical Psychology. 81: 1100-12. PMID 23937345 DOI: 10.1037/a0034120  0.92
2013 Smits JA, Rosenfield D, Otto MW, Marques L, Davis ML, Meuret AE, Simon NM, Pollack MH, Hofmann SG. D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions. Journal of Psychiatric Research. 47: 1455-61. PMID 23870811 DOI: 10.1016/j.jpsychires.2013.06.020  0.92
2013 McHugh RK, Whitton SW, Peckham AD, Welge JA, Otto MW. Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review. The Journal of Clinical Psychiatry. 74: 595-602. PMID 23842011 DOI: 10.4088/JCP.12r07757  0.92
2013 Stange JP, Sylvia LG, Magalhães PV, Frank E, Otto MW, Miklowitz DJ, Berk M, Nierenberg AA, Deckersbach T. Extreme attributions predict transition from depression to mania or hypomania in bipolar disorder. Journal of Psychiatric Research. 47: 1329-36. PMID 23791456 DOI: 10.1016/j.jpsychires.2013.05.016  0.92
2013 Hofmann SG, Smits JA, Rosenfield D, Simon N, Otto MW, Meuret AE, Marques L, Fang A, Tart C, Pollack MH. D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder. The American Journal of Psychiatry. 170: 751-8. PMID 23599046 DOI: 10.1176/appi.ajp.2013.12070974  0.92
2013 Harlow BL, MacLehose RF, Smolenski DJ, Soares CN, Otto MW, Joffe H, Cohen LS. Disparate rates of new-onset depression during the menopausal transition in 2 community-based populations: real, or really wrong? American Journal of Epidemiology. 177: 1148-56. PMID 23589585 DOI: 10.1093/aje/kws365  0.92
2013 Stange JP, Sylvia LG, da Silva Magalhães PV, Miklowitz DJ, Otto MW, Frank E, Berk M, Nierenberg AA, Deckersbach T. Extreme attributions predict the course of bipolar depression: results from the STEP-BD randomized controlled trial of psychosocial treatment. The Journal of Clinical Psychiatry. 74: 249-55. PMID 23561230 DOI: 10.4088/JCP.12m08019  0.92
2013 McHugh RK, Murray HW, Hearon BA, Pratt EM, Pollack MH, Safren SA, Otto MW. Predictors of dropout from psychosocial treatment in opioid-dependent outpatients. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 22: 18-22. PMID 23398222 DOI: 10.1111/j.1521-0391.2013.00317.x  0.92
2013 Smits JA, Rosenfield D, Otto MW, Powers MB, Hofmann SG, Telch MJ, Pollack MH, Tart CD. D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia. Biological Psychiatry. 73: 1054-8. PMID 23332511 DOI: 10.1016/j.biopsych.2012.12.009  0.92
2013 Asmundson GJ, Fetzner MG, Deboer LB, Powers MB, Otto MW, Smits JA. Let's get physical: a contemporary review of the anxiolytic effects of exercise for anxiety and its disorders. Depression and Anxiety. 30: 362-73. PMID 23300122 DOI: 10.1002/da.22043  0.92
2013 Moshier SJ, Ewen M, Otto MW. Impulsivity as a moderator of the intention-behavior relationship for illicit drug use in patients undergoing treatment. Addictive Behaviors. 38: 1651-5. PMID 23254213 DOI: 10.1016/j.addbeh.2012.09.008  0.56
2013 Otto MW, Wisniewski SR. CBT for treatment resistant depression. Lancet. 381: 352-3. PMID 23219571 DOI: 10.1016/S0140-6736(12)61844-3  0.92
2013 Calkins AW, Hearon BA, Capozzoli MC, Otto MW. Psychosocial predictors of sleep dysfunction: the role of anxiety sensitivity, dysfunctional beliefs, and neuroticism. Behavioral Sleep Medicine. 11: 133-43. PMID 23136825 DOI: 10.1080/15402002.2011.643968  0.96
2013 Tart CD, Handelsman PR, Deboer LB, Rosenfield D, Pollack MH, Hofmann SG, Powers MB, Otto MW, Smits JA. Augmentation of exposure therapy with post-session administration of D-cycloserine. Journal of Psychiatric Research. 47: 168-74. PMID 23098672 DOI: 10.1016/j.jpsychires.2012.09.024  0.92
2012 Smits JA, Zvolensky MJ, Rosenfield D, Marcus BH, Church TS, Frierson GM, Powers MB, Otto MW, Davis ML, DeBoer LB, Briceno NF. The efficacy of vigorous-intensity exercise as an aid to smoking cessation in adults with elevated anxiety sensitivity: study protocol for a randomized controlled trial. Trials. 13: 207. PMID 23148822 DOI: 10.1186/1745-6215-13-207  0.92
2012 McHugh RK, Weitzman M, Safren SA, Murray HW, Pollack MH, Otto MW. Sexual HIV risk behaviors in a treatment-refractory opioid-dependent sample. Journal of Psychoactive Drugs. 44: 237-42. PMID 23061323 DOI: 10.1080/02791072.2012.703507  0.92
2012 DeBoer LB, Powers MB, Utschig AC, Otto MW, Smits JA. Exploring exercise as an avenue for the treatment of anxiety disorders. Expert Review of Neurotherapeutics. 12: 1011-22. PMID 23002943 DOI: 10.1586/ern.12.73  0.92
2012 Farabaugh A, Alpert J, Wisniewski SR, Otto MW, Fava M, Baer L, Perlis R, Friedman E, Nyer M, Bitran S, Balasubramani GK, Inamori A, Trivedi M, Thase ME. Cognitive therapy for anxious depression in STAR(*) D: what have we learned? Journal of Affective Disorders. 142: 213-8. PMID 22877961 DOI: 10.1016/j.jad.2012.04.029  0.92
2012 Moshier SJ, McHugh RK, Calkins AW, Hearon BA, Rosellini AJ, Weitzman ML, Otto MW. The role of perceived belongingness to a drug subculture among opioid-dependent patients. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 26: 812-20. PMID 22732052 DOI: 10.1037/a0029107  0.92
2012 Otto MW, Tolin DF, Nations KR, Utschig AC, Rothbaum BO, Hofmann SG, Smits JA. Five sessions and counting: considering ultra-brief treatment for panic disorder. Depression and Anxiety. 29: 465-70. PMID 22730311 DOI: 10.1002/da.21910  0.96
2012 McHugh RK, Otto MW. Refining the measurement of distress intolerance. Behavior Therapy. 43: 641-51. PMID 22697451 DOI: 10.1016/j.beth.2011.12.001  1
2012 Litz BT, Salters-Pedneault K, Steenkamp MM, Hermos JA, Bryant RA, Otto MW, Hofmann SG. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. Journal of Psychiatric Research. 46: 1184-90. PMID 22694905 DOI: 10.1016/j.jpsychires.2012.05.006  0.92
2012 Safren SA, O'Cleirigh CM, Bullis JR, Otto MW, Stein MD, Pollack MH. Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial. Journal of Consulting and Clinical Psychology. 80: 404-15. PMID 22545737 DOI: 10.1037/a0028208  0.92
2012 Hinton DE, Rivera EI, Hofmann SG, Barlow DH, Otto MW. Adapting CBT for traumatized refugees and ethnic minority patients: examples from culturally adapted CBT (CA-CBT). Transcultural Psychiatry. 49: 340-65. PMID 22508639 DOI: 10.1177/1363461512441595  0.92
2012 Nations KR, Smits JA, Tolin DF, Rothbaum BO, Hofmann SG, Tart CD, Lee A, Schipper J, Sjogren M, Xue D, Szegedi A, Otto MW. Evaluation of the glycine transporter inhibitor Org 25935 as augmentation to cognitive-behavioral therapy for panic disorder: a multicenter, randomized, double-blind, placebo-controlled trial. The Journal of Clinical Psychiatry. 73: 647-53. PMID 22394471 DOI: 10.4088/JCP.11m07081  0.92
2012 Sung SC, Porter E, Robinaugh DJ, Marks EH, Marques LM, Otto MW, Pollack MH, Simon NM. Mood regulation and quality of life in social anxiety disorder: an examination of generalized expectancies for negative mood regulation. Journal of Anxiety Disorders. 26: 435-41. PMID 22343166 DOI: 10.1016/j.janxdis.2012.01.004  0.8
2012 McHugh RK, Otto MW. Profiles of distress intolerance in a substance-dependent sample. The American Journal of Drug and Alcohol Abuse. 38: 161-5. PMID 22185368 DOI: 10.3109/00952990.2011.643990  1
2011 McHugh RK, Daughters SB, Lejuez CW, Murray HW, Hearon BA, Gorka SM, Otto MW. Shared Variance among Self-Report and Behavioral Measures of Distress Intolerance. Cognitive Therapy and Research. 35: 266-275. PMID 23894216 DOI: 10.1007/s10608-010-9295-1  0.92
2011 Deckersbach T, Moshier SJ, Tuschen-Caffier B, Otto MW. Memory dysfunction in panic disorder: an investigation of the role of chronic benzodiazepine use. Depression and Anxiety. 28: 999-1007. PMID 22065537 DOI: 10.1002/da.20891  0.56
2011 McHugh RK, Otto MW. Domain-general and domain-specific strategies for the assessment of distress intolerance. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 25: 745-9. PMID 21823763 DOI: 10.1037/a0025094  1
2011 Weitzman ML, McHugh RK, Otto MW. The association between affect amplification and urgency. Depression and Anxiety. 28: 1105-10. PMID 21681865 DOI: 10.1002/da.20830  0.92
2011 McHugh RK, Rasmussen JL, Otto MW. Comprehension of self-report evidence-based measures of anxiety. Depression and Anxiety. 28: 607-14. PMID 21618668 DOI: 10.1002/da.20827  1
2011 McHugh RK, Hearon BA, Halperin DM, Otto MW. A novel method for assessing distress intolerance: adaptation of a measure of willingness to pay. Journal of Behavior Therapy and Experimental Psychiatry. 42: 440-6. PMID 21570933 DOI: 10.1016/j.jbtep.2011.04.003  0.92
2011 Hinton DE, Hofmann SG, Rivera E, Otto MW, Pollack MH. Culturally adapted CBT (CA-CBT) for Latino women with treatment-resistant PTSD: a pilot study comparing CA-CBT to applied muscle relaxation. Behaviour Research and Therapy. 49: 275-80. PMID 21333272 DOI: 10.1016/j.brat.2011.01.005  0.96
2011 Hofmann SG, Smits JA, Asnaani A, Gutner CA, Otto MW. Cognitive enhancers for anxiety disorders. Pharmacology, Biochemistry, and Behavior. 99: 275-84. PMID 21134394 DOI: 10.1016/j.pbb.2010.11.020  0.92
2011 Calkins AW, Deveney CM, Weitzman ML, Hearon BA, Siegle GJ, Otto MW. The effects of prior cognitive control task exposure on responses to emotional tasks in healthy participants. Behavioural and Cognitive Psychotherapy. 39: 205-20. PMID 21114896 DOI: 10.1017/S1352465810000652  0.92
2011 Hearon BA, Calkins AW, Halperin DM, McHugh RK, Murray HW, Otto MW. Anxiety sensitivity and illicit sedative use among opiate-dependent women and men. The American Journal of Drug and Alcohol Abuse. 37: 43-7. PMID 21090958 DOI: 10.3109/00952990.2010.535581  0.92
2010 Otto MW, McHugh RK, Kantak KM. Combined Pharmacotherapy and Cognitive-Behavioral Therapy for Anxiety Disorders: Medication Effects, Glucocorticoids, and Attenuated Treatment Outcomes. Clinical Psychology : a Publication of the Division of Clinical Psychology of the American Psychological Association. 17: 91-103. PMID 26855480 DOI: 10.1111/j.1468-2850.2010.01198.x  0.92
2010 Applebaum AJ, Bullis JR, Traeger LN, O'cleirigh C, Otto MW, Pollack MH, Safren SA. Rates of mood and anxiety disorders and contributors to continued heroin use in methadone maintenance patients: A comparison by HIV status. Neurobehavioral Hiv Medicine. 2010: 49-57. PMID 24062619 DOI: 10.2147/NBHIV.S12371  0.8
2010 Peckham AD, McHugh RK, Otto MW. A meta-analysis of the magnitude of biased attention in depression. Depression and Anxiety. 27: 1135-42. PMID 21049527 DOI: 10.1002/da.20755  1
2010 McHugh RK, Murray HW, Hearon BA, Calkins AW, Otto MW. Attentional bias and craving in smokers: the impact of a single attentional training session. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 12: 1261-4. PMID 20961974 DOI: 10.1093/ntr/ntq171  1
2010 Safren SA, Sprich S, Mimiaga MJ, Surman C, Knouse L, Groves M, Otto MW. Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. Jama. 304: 875-80. PMID 20736471 DOI: 10.1001/jama.2010.1192  0.92
2010 McHugh RK, Hearon BA, Otto MW. Cognitive behavioral therapy for substance use disorders. The Psychiatric Clinics of North America. 33: 511-25. PMID 20599130 DOI: 10.1016/j.psc.2010.04.012  1
2010 Otto MW, McHugh RK, Simon NM, Farach FJ, Worthington JJ, Pollack MH. Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation. Behaviour Research and Therapy. 48: 720-7. PMID 20546699 DOI: 10.1016/j.brat.2010.04.002  1
2010 Murray HW, McHugh RK, Rowley TC, Sirota AD, Otto MW. Development and validation of the smoking cue appeal survey. Substance Use & Misuse. 45: 2152-61. PMID 20469971 DOI: 10.3109/10826084.2010.481771  0.92
2010 Ocañez KL, McHugh RK, Otto MW. A meta-analytic review of the association between anxiety sensitivity and pain. Depression and Anxiety. 27: 760-7. PMID 20336798 DOI: 10.1002/da.20681  1
2010 Behar E, McHugh RK, Peckham A, Otto MW. D-cycloserine for the augmentation of an attentional training intervention for trait anxiety. Journal of Anxiety Disorders. 24: 440-5. PMID 20236791 DOI: 10.1016/j.janxdis.2010.02.009  0.92
2010 McHugh RK, Behar E, Gutner CA, Geem D, Otto MW. Cortisol, stress, and attentional bias toward threat. Anxiety, Stress, and Coping. 23: 529-45. PMID 20191400 DOI: 10.1080/10615801003596969  0.92
2010 McHugh RK, Hofmann SG, Asnaani A, Sawyer AT, Otto MW. The serotonin transporter gene and risk for alcohol dependence: a meta-analytic review. Drug and Alcohol Dependence. 108: 1-6. PMID 20060655 DOI: 10.1016/j.drugalcdep.2009.11.017  0.92
2010 Applebaum AJ, Otto MW, Richardson MA, Safren SA. Contributors to neuropsychological impairment in HIV-infected and HIV-uninfected opiate-dependent patients Journal of Clinical and Experimental Neuropsychology. 32: 579-589. PMID 19890760 DOI: 10.1080/13803390903313572  0.92
2010 Otto MW, Tolin DF, Simon NM, Pearlson GD, Basden S, Meunier SA, Hofmann SG, Eisenmenger K, Krystal JH, Pollack MH. Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder. Biological Psychiatry. 67: 365-70. PMID 19811776 DOI: 10.1016/j.biopsych.2009.07.036  0.92
2010 Nic Dhonnchadha BA, Szalay JJ, Achat-Mendes C, Platt DM, Otto MW, Spealman RD, Kantak KM. D-cycloserine deters reacquisition of cocaine self-administration by augmenting extinction learning. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 357-67. PMID 19741593 DOI: 10.1038/npp.2009.139  0.92
2010 Smits JAJ, Tart CD, Presnell K, Rosenfield D, Otto MW. Identifying potential barriers to physical activity adherence: Anxiety sensitivity and body mass as predictors of fear during exercise Cognitive Behaviour Therapy. 39: 28-36. PMID 19675961 DOI: 10.1080/16506070902915261  0.92
2010 Reilly-Harrington NA, Miklowitz DJ, Otto MW, Frank E, Wisniewski SR, Thase ME, Sachs GS. Dysfunctional attitudes, attributional styles, and phase of illness in bipolar disorder Cognitive Therapy and Research. 34: 24-34. DOI: 10.1007/s10608-008-9218-6  0.92
2009 Simon NM, Otto MW, Worthington JJ, Hoge EA, Thompson EH, Lebeau RT, Moshier SJ, Zalta AK, Pollack MH. Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial. The Journal of Clinical Psychiatry. 70: 1563-70. PMID 19814948 DOI: 10.4088/JCP.08m04485blu  0.92
2009 McHugh RK, Smits JA, Otto MW. Empirically supported treatments for panic disorder. The Psychiatric Clinics of North America. 32: 593-610. PMID 19716992 DOI: 10.1016/j.psc.2009.05.005  1
2009 Calkins AW, Otto MW, Cohen LS, Soares CN, Vitonis AF, Hearon BA, Harlow BL. Psychosocial predictors of the onset of anxiety disorders in women: results from a prospective 3-year longitudinal study. Journal of Anxiety Disorders. 23: 1165-9. PMID 19699609 DOI: 10.1016/j.janxdis.2009.07.022  0.92
2009 Hinton DE, Hofmann SG, Pollack MH, Otto MW. Mechanisms of efficacy of CBT for Cambodian refugees with PTSD: improvement in emotion regulation and orthostatic blood pressure response. Cns Neuroscience & Therapeutics. 15: 255-63. PMID 19691545 DOI: 10.1111/j.1755-5949.2009.00100.x  0.96
2009 Marques L, Kaufman RE, LeBeau RT, Moshier SJ, Otto MW, Pollack MH, Simon NM. A comparison of emotional approach coping (EAC) between individuals with anxiety disorders and nonanxious controls. Cns Neuroscience & Therapeutics. 15: 100-6. PMID 19492991 DOI: 10.1111/j.1755-5949.2009.00080.x  0.8
2009 Powers MB, Smits JA, Otto MW, Sanders C, Emmelkamp PM. Facilitation of fear extinction in phobic participants with a novel cognitive enhancer: a randomized placebo controlled trial of yohimbine augmentation. Journal of Anxiety Disorders. 23: 350-6. PMID 19223151 DOI: 10.1016/j.janxdis.2009.01.001  0.92
2009 Safren SA, O'Cleirigh C, Tan JY, Raminani SR, Reilly LC, Otto MW, Mayer KH. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association. 28: 1-10. PMID 19210012 DOI: 10.1037/a0012715  0.92
2009 Otto MW, Basden SL, McHugh RK, Kantak KM, Deckersbach T, Cather C, Goff DC, Hofmann SG, Berry AC, Smits JA. Effects of D-cycloserine administration on weekly nonemotional memory tasks in healthy participants. Psychotherapy and Psychosomatics. 78: 49-54. PMID 19018157 DOI: 10.1159/000172620  0.92
2008 Murray H, McHugh RK, Behar E, Pratt E, Otto M. Personality factors associated with methadone maintenance dose. The American Journal of Drug and Alcohol Abuse. 34: 634-41. PMID 18821457 DOI: 10.1080/00952990802308163  0.92
2008 Smits JA, Berry AC, Rosenfield D, Powers MB, Behar E, Otto MW. Reducing anxiety sensitivity with exercise. Depression and Anxiety. 25: 689-99. PMID 18729145 DOI: 10.1002/da.20411  0.92
2008 Lejuez CW, Zvolensky MJ, Daughters SB, Bornovalova MA, Paulson A, Tull MT, Ettinger K, Otto MW. Anxiety sensitivity: a unique predictor of dropout among inner-city heroin and crack/cocaine users in residential substance use treatment. Behaviour Research and Therapy. 46: 811-8. PMID 18466878 DOI: 10.1016/j.brat.2008.03.010  0.92
2008 Simon NM, Connor KM, Lang AJ, Rauch S, Krulewicz S, LeBeau RT, Davidson JR, Stein MB, Otto MW, Foa EB, Pollack MH. Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy. The Journal of Clinical Psychiatry. 69: 400-5. PMID 18348595  0.92
2008 Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW. A meta-analytic review of psychosocial interventions for substance use disorders. The American Journal of Psychiatry. 165: 179-87. PMID 18198270 DOI: 10.1176/appi.ajp.2007.06111851  0.96
2008 Pollack MH, Otto MW, Roy-Byrne PP, Coplan JD, Rothbaum BO, Simon NM, Gorman JM. Novel treatment approaches for refractory anxiety disorders. Depression and Anxiety. 25: 467-76. PMID 17437259 DOI: 10.1002/da.20329  0.8
2008 Otto MW, Behar E, Smits JAJ, Hofmann SG. Combining Pharmacological and Cognitive Behavioral Therapy in the Treatment of Anxiety Disorders Oxford Handbook of Anxiety and Related Disorders. DOI: 10.1093/oxfordhb/9780195307030.013.0032  0.92
2008 Soroudi N, Perez GK, Gonzalez JS, Greer JA, Pollack MH, Otto MW, Safren SA. CBT for Medication Adherence and Depression (CBT-AD) in HIV-Infected Patients Receiving Methadone Maintenance Therapy Cognitive and Behavioral Practice. 15: 93-106. DOI: 10.1016/j.cbpra.2006.11.004  0.92
2008 Smits JAJ, Powers MB, Berry AC, Otto MW. Translating empirically supported strategies into accessible interventions: The potential utility of exercise for the treatment of panic disorder Wiadomosci Psychiatryczne. 11: 300-313. DOI: 10.1016/j.cbpra.2006.07.005  0.92
2007 Miklowitz DJ, Otto MW. Psychosocial interventions for bipolar disorder: a review of literature and introduction of the systematic treatment enhancement program. Psychopharmacology Bulletin. 40: 116-31. PMID 18227782  0.92
2007 Otto MW, Church TS, Craft LL, Greer TL, Smits JA, Trivedi MH. Exercise for mood and anxiety disorders. Primary Care Companion to the Journal of Clinical Psychiatry. 9: 287-94. PMID 17934553  0.92
2007 Miklowitz DJ, Otto MW, Frank E, Reilly-Harrington NA, Kogan JN, Sachs GS, Thase ME, Calabrese JR, Marangell LB, Ostacher MJ, Patel J, Thomas MR, Araga M, Gonzalez JM, Wisniewski SR. Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial. The American Journal of Psychiatry. 164: 1340-7. PMID 17728418 DOI: 10.1176/appi.ajp.2007.07020311  0.92
2007 Otto MW, Teachman BA, Cohen LS, Soares CN, Vitonis AF, Harlow BL. Dysfunctional attitudes and episodes of major depression: Predictive validity and temporal stability in never-depressed, depressed, and recovered women. Journal of Abnormal Psychology. 116: 475-83. PMID 17696703 DOI: 10.1037/0021-843X.116.3.475  0.92
2007 McHugh RK, Otto MW, Barlow DH, Gorman JM, Shear MK, Woods SW. Cost-efficacy of individual and combined treatments for panic disorder. The Journal of Clinical Psychiatry. 68: 1038-44. PMID 17685740  0.92
2007 Otto MW, O' Cleirigh CM, Pollack MH. Attending to emotional cues for drug abuse: bridging the gap between clinic and home behaviors. Science & Practice Perspectives. 3: 48-56. PMID 17514074  0.8
2007 Otto MW, Church TS, Craft LL, Greer TL, Smits JA, Trivedi MH. Exercise for mood and anxiety disorders. The Journal of Clinical Psychiatry. 68: 669-76. PMID 17503975 DOI: 10.4088/JCP.V68N0515  0.92
2007 Miklowitz DJ, Otto MW, Frank E, Reilly-Harrington NA, Wisniewski SR, Kogan JN, Nierenberg AA, Calabrese JR, Marangell LB, Gyulai L, Araga M, Gonzalez JM, Shirley ER, Thase ME, Sachs GS. Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program. Archives of General Psychiatry. 64: 419-26. PMID 17404119 DOI: 10.1001/archpsyc.64.4.419  0.92
2007 Sachs GS, Nierenberg AA, Calabrese JR, Marangell LB, Wisniewski SR, Gyulai L, Friedman ES, Bowden CL, Fossey MD, Ostacher MJ, Ketter TA, Patel J, Hauser P, Rapport D, Martinez JM, ... ... Otto MW, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. The New England Journal of Medicine. 356: 1711-22. PMID 17392295 DOI: 10.1056/NEJMoa064135  0.92
2007 Otto MW, Henin A, Hirshfeld-Becker DR, Pollack MH, Biederman J, Rosenbaum JF. Posttraumatic stress disorder symptoms following media exposure to tragic events: impact of 9/11 on children at risk for anxiety disorders. Journal of Anxiety Disorders. 21: 888-902. PMID 17276653 DOI: 10.1016/j.janxdis.2006.10.008  0.8
2007 Otto MW, Basden SL, Leyro TM, McHugh RK, Hofmann SG. Clinical perspectives on the combination of D-cycloserine and cognitive-behavioral therapy for the treatment of anxiety disorders. Cns Spectrums. 12: 51-6, 59-61. PMID 17192764  1
2007 Otto MW, Leyro TM, Christian K, Deveney CM, Reese H, Pollack MH, Orr SP. Prediction of "fear" acquisition in healthy control participants in a de novo fear-conditioning paradigm. Behavior Modification. 31: 32-51. PMID 17179530 DOI: 10.1177/0145445506295054  0.92
2007 Simon NM, Zalta AK, Otto MW, Ostacher MJ, Fischmann D, Chow CW, Thompson EH, Stevens JC, Demopulos CM, Nierenberg AA, Pollack MH. The association of comorbid anxiety disorders with suicide attempts and suicidal ideation in outpatients with bipolar disorder. Journal of Psychiatric Research. 41: 255-64. PMID 17052730 DOI: 10.1016/j.jpsychires.2006.08.004  0.92
2007 Simon NM, Pollack MH, Ostacher MJ, Zalta AK, Chow CW, Fischmann D, Demopulos CM, Nierenberg AA, Otto MW. Understanding the link between anxiety symptoms and suicidal ideation and behaviors in outpatients with bipolar disorder. Journal of Affective Disorders. 97: 91-9. PMID 16820212 DOI: 10.1016/j.jad.2006.05.027  0.92
2007 Miklowitz DJ, Otto MW, Frank E, Reilly-Harrington NA, Wisniewski SR, Kogan JN, Nierenberg AA, Calabrese JR, Marangell LB, Gyulai L, Araga M, Gonzalez JM, Shirley ER, Thase ME, Sachs GS. In reply [3] Archives of General Psychiatry. 64: 1452-1453. DOI: 10.1001/archpsyc.64.12.1452  0.92
2006 Hofmann SG, Pollack MH, Otto MW. Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine. Cns Drug Reviews. 12: 208-17. PMID 17227287 DOI: 10.1111/j.1527-3458.2006.00208.x  0.96
2006 Simon NM, Weiss AM, Kradin R, Evans KC, Reese HE, Otto MW, Oppenheimer JE, Smoller JW, Zalta A, Worthington JJ, Pollack MH. The relationship of anxiety disorders, anxiety sensitivity and pulmonary dysfunction with dyspnea-related distress and avoidance. The Journal of Nervous and Mental Disease. 194: 951-7. PMID 17164635 DOI: 10.1097/01.nmd.0000249062.25829.53  0.92
2006 Davis M, Barad M, Otto M, Southwick S. Combining pharmacotherapy with cognitive behavioral therapy: traditional and new approaches. Journal of Traumatic Stress. 19: 571-81. PMID 17075906 DOI: 10.1002/jts.20149  0.92
2006 Marangell LB, Bauer MS, Dennehy EB, Wisniewski SR, Allen MH, Miklowitz DJ, Oquendo MA, Frank E, Perlis RH, Martinez JM, Fagiolini A, Otto MW, Chessick CA, Zboyan HA, Miyahara S, et al. Prospective predictors of suicide and suicide attempts in 1,556 patients with bipolar disorders followed for up to 2 years. Bipolar Disorders. 8: 566-75. PMID 17042830 DOI: 10.1111/j.1399-5618.2006.00369.x  0.92
2006 Otto MW, Simon NM, Wisniewski SR, Miklowitz DJ, Kogan JN, Reilly-Harrington NA, Frank E, Nierenberg AA, Marangell LB, Sagduyu K, Weiss RD, Miyahara S, Thas ME, Sachs GS, Pollack MH, et al. Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. The British Journal of Psychiatry : the Journal of Mental Science. 189: 20-5. PMID 16816301 DOI: 10.1192/bjp.bp.104.007773  0.92
2006 Miklowitz DJ, Otto MW, Wisniewski SR, Araga M, Frank E, Reilly-Harrington NA, Lembke A, Sachs GS. Psychotherapy, symptom outcomes, and role functioning over one year among patients with bipolar disorder. Psychiatric Services (Washington, D.C.). 57: 959-65. PMID 16816280 DOI: 10.1176/ps.2006.57.7.959  0.92
2006 Pollack MH, Simon NM, Fagiolini A, Pitman R, McNally RJ, Nierenberg AA, Miyahara S, Sachs GS, Perlman C, Ghaemi SN, Thase ME, Otto MW. Persistent posttraumatic stress disorder following September 11 in patients with bipolar disorder. The Journal of Clinical Psychiatry. 67: 394-9. PMID 16649825  0.92
2006 Fossey MD, Otto MW, Yates WR, Wisniewski SR, Gyulai L, Allen MH, Miklowitz DJ, Coon KA, Ostacher MJ, Neel JL, Thase ME, Sachs GS, Weiss RD. Validity of the distinction between primary and secondary substance use disorder in patients with bipolar disorder: data from the first 1000 STEP-BD participants. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 15: 138-43. PMID 16595351 DOI: 10.1080/10550490500528423  0.92
2006 Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Archives of General Psychiatry. 63: 385-90. PMID 16585467 DOI: 10.1001/archpsyc.63.4.385  0.92
2006 Hofmann SG, Meuret AE, Smits JA, Simon NM, Pollack MH, Eisenmenger K, Shiekh M, Otto MW. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Archives of General Psychiatry. 63: 298-304. PMID 16520435 DOI: 10.1001/archpsyc.63.3.298  0.92
2006 Couture SM, Roberts DL, Penn DL, Cather C, Otto MW, Goff D. Do baseline client characteristics predict the therapeutic alliance in the treatment of schizophrenia? The Journal of Nervous and Mental Disease. 194: 10-4. PMID 16462549 DOI: 10.1097/01.nmd.0000195315.39196.52  0.92
2006 Perlis RH, Ostacher MJ, Patel JK, Marangell LB, Zhang H, Wisniewski SR, Ketter TA, Miklowitz DJ, Otto MW, Gyulai L, Reilly-Harrington NA, Nierenberg AA, Sachs GS, Thase ME. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). The American Journal of Psychiatry. 163: 217-24. PMID 16449474 DOI: 10.1176/appi.ajp.163.2.217  0.92
2006 Otto MW, Simon NM, Powers M, Hinton D, Zalta AK, Pollack MH. Rates of isolated sleep paralysis in outpatients with anxiety disorders. Journal of Anxiety Disorders. 20: 687-93. PMID 16099138 DOI: 10.1016/j.janxdis.2005.07.002  0.92
2006 Miklowitz DJ, Otto MW. New psychosocial interventions for bipolar disorder: A review of literature and introduction of the systematic treatment enhancement program Journal of Cognitive Psychotherapy. 20: 215-230. DOI: 10.1891/jcop.20.2.215  0.92
2006 Stathopoulou G, Powers MB, Berry AC, Smits JAJ, Otto MW. Exercise interventions for mental health: A quantitative and qualitative review Clinical Psychology: Science and Practice. 13: 179-193. DOI: 10.1111/j.1468-2850.2006.00021.x  0.92
2005 Miklowitz DJ, Wisniewski SR, Miyahara S, Otto MW, Sachs GS. Perceived criticism from family members as a predictor of the one-year course of bipolar disorder. Psychiatry Research. 136: 101-11. PMID 16023735 DOI: 10.1016/j.psychres.2005.04.005  0.92
2005 Otto MW, Powers MB, Fischmann D. Emotional exposure in the treatment of substance use disorders: conceptual model, evidence, and future directions. Clinical Psychology Review. 25: 824-39. PMID 15967554 DOI: 10.1016/j.cpr.2005.05.002  0.92
2005 Weiss RD, Ostacher MJ, Otto MW, Calabrese JR, Fossey M, Wisniewski SR, Bowden CL, Nierenberg AA, Pollack MH, Salloum IM, Simon NM, Thase ME, Sachs GS. Does recovery from substance use disorder matter in patients with bipolar disorder? The Journal of Clinical Psychiatry. 66: 730-5; quiz 808-9. PMID 15960566 DOI: 10.4088/JCP.v66n0609  0.8
2005 Wright JH, Wright AS, Albano AM, Basco MR, Goldsmith LJ, Raffield T, Otto MW. Computer-assisted cognitive therapy for depression: Maintaining efficacy while reducing therapist time American Journal of Psychiatry. 162: 1158-1164. PMID 15930065 DOI: 10.1176/appi.ajp.162.6.1158  0.92
2005 Simon NM, Otto MW, Fischmann D, Racette S, Nierenberg AA, Pollack MH, Smoller JW. Panic disorder and bipolar disorder: anxiety sensitivity as a potential mediator of panic during manic states. Journal of Affective Disorders. 87: 101-5. PMID 15894380 DOI: 10.1016/j.jad.2005.02.004  0.8
2005 Kolodziej ME, Griffin ML, Najavits LM, Otto MW, Greenfield SF, Weiss RD. Anxiety disorders among patients with co-occurring bipolar and substance use disorders Drug and Alcohol Dependence. 80: 251-257. PMID 15876498 DOI: 10.1016/j.drugalcdep.2005.04.003  0.92
2005 Cather C, Penn D, Otto MW, Yovel I, Mueser KT, Goff DC. A pilot study of functional Cognitive Behavioral Therapy (fCBT) for schizophrenia. Schizophrenia Research. 74: 201-9. PMID 15722000 DOI: 10.1016/j.schres.2004.05.002  0.92
2005 Otto MW, Smits JAJ, Reese HE. Combined psychotherapy and pharmacotherapy for mood and anxiety disorders in adults: Review and analysis Clinical Psychology: Science and Practice. 12: 72-86. DOI: 10.1093/clipsy/bpi009  0.92
2004 Simon NM, Otto MW, Wisniewski SR, Fossey M, Sagduyu K, Frank E, Sachs GS, Nierenberg AA, Thase ME, Pollack MH. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). The American Journal of Psychiatry. 161: 2222-9. PMID 15569893 DOI: 10.1176/appi.ajp.161.12.2222  0.8
2004 Otto MW, Perlman CA, Wernicke R, Reese HE, Bauer MS, Pollack MH. Posttraumatic stress disorder in patients with bipolar disorder: a review of prevalence, correlates, and treatment strategies. Bipolar Disorders. 6: 470-9. PMID 15541062 DOI: 10.1111/j.1399-5618.2004.00151.x  0.92
2004 Kogan JN, Otto MW, Bauer MS, Dennehy EB, Miklowitz DJ, Zhang HW, Ketter T, Rudorfer MV, Wisniewski SR, Thase ME, Calabrese J, Sachs GS. Demographic and diagnostic characteristics of the first 1000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Bipolar Disorders. 6: 460-9. PMID 15541061 DOI: 10.1111/j.1399-5618.2004.00158.x  0.92
2004 Otto MW, Miklowitz DJ. The role and impact of psychotherapy in the management of bipolar disorder. Cns Spectrums. 9: 27-32. PMID 15529090  0.92
2004 Jacobs GD, Pace-Schott EF, Stickgold R, Otto MW. Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. Archives of Internal Medicine. 164: 1888-96. PMID 15451764 DOI: 10.1001/archinte.164.17.1888  0.92
2004 Simon NM, Otto MW, Smits JA, Nicolaou DC, Reese HE, Pollack MH. Changes in anxiety sensitivity with pharmacotherapy for panic disorder. Journal of Psychiatric Research. 38: 491-5. PMID 15380399 DOI: 10.1016/j.jpsychires.2004.01.004  0.92
2004 Simon NM, Otto MW, Weiss RD, Bauer MS, Miyahara S, Wisniewski SR, Thase ME, Kogan J, Frank E, Nierenberg AA, Calabrese JR, Sachs GS, Pollack MH. Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD. Journal of Clinical Psychopharmacology. 24: 512-20. PMID 15349007 DOI: 10.1097/01.jcp.0000138772.40515.70  0.8
2004 Lembke A, Miklowitz DJ, Otto MW, Zhang H, Wisniewski SR, Sachs GS, Thase ME, Ketter TA. Psychosocial service utilization by patients with bipolar disorders: data from the first 500 participants in the Systematic Treatment Enhancement Program. Journal of Psychiatric Practice. 10: 81-7. PMID 15330403 DOI: 10.1097/00131746-200403000-00002  0.92
2004 Penn DL, Mueser KT, Tarrier N, Gloege A, Cather C, Serrano D, Otto MW. Supportive therapy for schizophrenia: possible mechanisms and implications for adjunctive psychosocial treatments. Schizophrenia Bulletin. 30: 101-12. PMID 15176765 DOI: 10.1093/OXFORDJOURNALS.SCHBUL.A007055  0.92
2004 Harlow BL, Cohen LS, Otto MW, Spiegelman D, Cramer DW. Early life menstrual characteristics and pregnancy experiences among women with and without major depression: the Harvard study of moods and cycles. Journal of Affective Disorders. 79: 167-76. PMID 15023491 DOI: 10.1016/S0165-0327(02)00459-7  0.92
2004 Safren SA, Hendriksen ES, Mayer KH, Mimiaga MJ, Pickard R, Otto MW. Cognitive-behavioral therapy for HIV medication adherence and depression Cognitive and Behavioral Practice. 11: 415-424. DOI: 10.1016/S1077-7229(04)80058-0  0.92
2004 Pollack MH, Otto MW, Bernstein JG, Rosenbaum JF. Anxious Patients Massachusetts General Hospital Handbook of General Hospital Psychiatry. 175-201. DOI: 10.1016/B978-0-323-02767-0.50019-X  0.92
2003 Blais MA, Holdwick DJ, McLean RY, Otto MW, Pollack MH, Hilsenroth MJ. Exploring the psychometric properties and construct validity of the MCMI-III anxiety and avoidant personality scales. Journal of Personality Assessment. 81: 237-41. PMID 14638448 DOI: 10.1207/S15327752JPA8103_06  0.92
2003 Pollack MH, Simon NM, Worthington JJ, Doyle AL, Peters P, Toshkov F, Otto MW. Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorder. Journal of Psychopharmacology (Oxford, England). 17: 276-82. PMID 14513919 DOI: 10.1177/02698811030173009  0.92
2003 Pollack MH, Meoni P, Otto MW, Simon N, Hackett D. Predictors of outcome following venlafaxine extended-release treatment of DSM-IV generalized anxiety disorder: a pooled analysis of short- and long-term studies. Journal of Clinical Psychopharmacology. 23: 250-9. PMID 12826987 DOI: 10.1097/01.jcp.0000084025.22282.84  0.8
2003 Sachs GS, Thase ME, Otto MW, Bauer M, Miklowitz D, Wisniewski SR, Lavori P, Lebowitz B, Rudorfer M, Frank E, Nierenberg AA, Fava M, Bowden C, Ketter T, Marangell L, et al. Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biological Psychiatry. 53: 1028-42. PMID 12788248 DOI: 10.1016/S0006-3223(03)00165-3  0.92
2003 Rayburn NR, Otto MW. Cognitive-behavioral therapy for panic disorder: A review of treatment elements, strategies and outcomes Cns Spectrums. 8: 356-362. PMID 12766691  0.92
2003 Harlow BL, Wise LA, Otto MW, Soares CN, Cohen LS. Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: the Harvard Study of Moods and Cycles. Archives of General Psychiatry. 60: 29-36. PMID 12511170 DOI: 10.1001/ARCHPSYC.60.1.29  0.92
2002 Pollack MH, Penava SA, Bolton E, Worthington JJ, Allen GL, Farach FJ, Otto MW. A novel cognitive-behavioral approach for treatment-resistant drug dependence. Journal of Substance Abuse Treatment. 23: 335-42. PMID 12495795 DOI: 10.1016/S0740-5472(02)00298-2  0.8
2002 Safren SA, Radomsky AS, Otto MW, Salomon E. Predictors of psychological well-being in a diverse sample of HIV-positive patients receiving highly active antiretroviral therapy. Psychosomatics. 43: 478-85. PMID 12444231 DOI: 10.1176/appi.psy.43.6.478  0.52
2002 Cohen LS, Soares CN, Otto MW, Sweeney BH, Liberman RF, Harlow BL. Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. The Harvard Study of Moods and Cycles. Journal of Affective Disorders. 70: 125-32. PMID 12117624 DOI: 10.1016/S0165-0327(01)00458-X  0.92
2002 Simon NM, Blacker D, Korbly NB, Sharma SG, Worthington JJ, Otto MW, Pollack MH. Hypothyroidism and hyperthyroidism in anxiety disorders revisited: new data and literature review. Journal of Affective Disorders. 69: 209-17. PMID 12103468 DOI: 10.1016/S0165-0327(01)00378-0  0.92
2002 Simon NM, Safren SA, Otto MW, Sharma SG, Lanka GD, Pollack MH. Longitudinal outcome with pharmacotherapy in a naturalistic study of panic disorder. Journal of Affective Disorders. 69: 201-8. PMID 12103467 DOI: 10.1016/S0165-0327(01)00359-7  0.92
2002 Simon NM, Otto MW, Korbly NB, Peters PM, Nicolaou DC, Pollack MH. Quality of life in social anxiety disorder compared with panic disorder and the general population. Psychiatric Services (Washington, D.C.). 53: 714-8. PMID 12045308 DOI: 10.1176/appi.ps.53.6.714  0.92
2002 Harlow BL, Cohen LS, Otto MW, Liberman RF, Spiegelman D, Cramer DW. Demographic, family, and occupational characteristics associated with major depression: the Harvard study of moods and cycles. Acta Psychiatrica Scandinavica. 105: 209-17. PMID 11939975 DOI: 10.1034/j.1600-0447.2002.1o102.x  0.92
2002 Otto MW, Hong JJ, Safren SA. Benzodiazepine discontinuation difficulties in panic disorder: Conceptual model and outcome for cognitive-behavior therapy Current Pharmaceutical Design. 8: 75-80. PMID 11812251 DOI: 10.2174/1381612023396726  0.92
2001 Otto MW, Pollack MH, Maki KM, Gould RA, Worthington JJ, Smoller JW, Rosenbaum JF. Childhood history of anxiety disorders among adults with social phobia: rates, correlates, and comparisons with patients with panic disorder. Depression and Anxiety. 14: 209-13. PMID 11754127 DOI: 10.1002/da.1068  0.92
2001 Soares CN, Cohen LS, Otto MW, Harlow BL. Characteristics of women with premenstrual dysphoric disorder (PMDD) who did or did not report history of depression: a preliminary report from the Harvard Study of Moods and Cycles. Journal of Women's Health & Gender-Based Medicine. 10: 873-8. PMID 11747682 DOI: 10.1089/152460901753285778  0.92
2001 Otto MW, Wilhelm S, Cohen LS, Harlow BL. Prevalence of body dysmorphic disorder in a community sample of women. The American Journal of Psychiatry. 158: 2061-3. PMID 11729026 DOI: 10.1176/appi.ajp.158.12.2061  0.92
2001 Otto MW, Tuby KS, Gould RA, McLean RY, Pollack MH. An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder. The American Journal of Psychiatry. 158: 1989-92. PMID 11729014 DOI: 10.1176/appi.ajp.158.12.1989  0.92
2001 Blais MA, Otto MW, Zucker BG, McNally RJ, Schmidt NB, Fava M, Pollack MH. The anxiety sensitivity index: item analysis and suggestions for refinement. Journal of Personality Assessment. 77: 272-94. PMID 11693859 DOI: 10.1207/S15327752JPA7702_10  0.8
2001 Whittal ML, Otto MW, Hong JJ. Cognitive-behavior therapy for discontinuation of SSRI treatment of panic disorder: A case series Behaviour Research and Therapy. 39: 939-945. PMID 11480834 DOI: 10.1016/S0005-7967(00)00067-X  0.92
2001 Katherine Shear M, Bilt JV, Rucci P, Endicott J, Lydiard B, Otto MW, Pollack MH, Chandler L, Williams J, Ali A, Frank DM. Reliability and validity of a Structured Interview Guide for the Hamilton Anxiety Rating Scale (SIGH-A) Depression and Anxiety. 13: 166-178. PMID 11413563 DOI: 10.1002/da.1033  0.92
2001 Henin A, Savage CR, Rauch SL, Deckersbach T, Wilhelm S, Baer L, Otto MW, Jenike MA. Is age at symptom onset associated with severity of memory impairment in adults with obsessive-compulsive disorder? The American Journal of Psychiatry. 158: 137-9. PMID 11136649 DOI: 10.1176/appi.ajp.158.1.137  0.92
2000 Deckersbach T, Savage CR, Henin A, Mataix-Cols D, Otto MW, Wilhelm S, Rauch SL, Baer L, Jenike MA. Reliability and validity of a scoring system for measuring organizational approach in the Complex Figure Test. Journal of Clinical and Experimental Neuropsychology. 22: 640-8. PMID 11094399 DOI: 10.1076/1380-3395(200010)22:5;1-9;FT640  0.92
2000 Otto MW, Pollack MH, Gould RA, Worthington JJ, McArdle ET, Rosenbaum JF. A comparison of the efficacy of clonazepam and cognitive-behavioral group therapy for the treatment of social phobia. Journal of Anxiety Disorders. 14: 345-58. PMID 11043885 DOI: 10.1016/S0887-6185(00)00027-X  0.92
2000 Manfro GG, Pollack MH, Otto MW, Worthington JJ, Rosenbaum JF, Scott EL, Kradin RL. Cell-surface expression of L-selectin (CD62L) by blood lymphocytes: correlates with affective parameters and severity of panic disorder. Depression and Anxiety. 11: 31-7. PMID 10723633 DOI: 10.1002/(SICI)1520-6394(2000)11:1<31::AID-DA5>3.0.CO;2-O  0.92
2000 Deckersbach T, Otto MW, Savage CR, Baer L, Jenike MA. The relationship between semantic organization and memory in obsessive-compulsive disorder. Psychotherapy and Psychosomatics. 69: 101-7. PMID 10671831 DOI: 10.1159/000012373  0.92
1999 Scott EL, Pollack MH, Otto MW, Simon NM, Worthington JJ. Clinician response to treatment refractory panic disorder: a survey of psychiatrists. The Journal of Nervous and Mental Disease. 187: 755-7. PMID 10665472 DOI: 10.1097/00005053-199912000-00009  0.92
1999 McNally RJ, Otto MW, Yap L, Pollack MH, Hornig CD. Is panic disorder linked to cognitive avoidance of threatening information? Journal of Anxiety Disorders. 13: 335-48. PMID 10504105 DOI: 10.1016/S0887-6185(99)00008-0  0.8
1999 Otto MW, Pollack MH, Penava SJ, Zucker BG. Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: a clinical case series. Behaviour Research and Therapy. 37: 763-70. PMID 10452176 DOI: 10.1016/S0005-7967(98)00176-4  0.8
1999 Candilis PJ, McLean RY, Otto MW, Manfro GG, Worthington JJ, Penava SJ, Marzol PC, Pollack MH. Quality of life in patients with panic disorder. The Journal of Nervous and Mental Disease. 187: 429-34. PMID 10426463 DOI: 10.1097/00005053-199907000-00006  0.8
1999 Harlow BL, Cohen LS, Otto MW, Spiegelman D, Cramer DW. Prevalence and predictors of depressive symptoms in older premenopausal women: the Harvard Study of Moods and Cycles. Archives of General Psychiatry. 56: 418-24. PMID 10232296 DOI: 10.1001/archpsyc.56.5.418  0.92
1999 Wilhelm S, Otto MW, Lohr B, Deckersbach T. Cognitive behavior group therapy for body dysmorphic disorder: a case series. Behaviour Research and Therapy. 37: 71-5. PMID 9922559 DOI: 10.1016/S0005-7967(98)00109-0  0.48
1998 Worthington JJ, Zucker BG, Fones CS, Otto MW, Pollack MH. Nefazodone for social phobia: a clinical case series. Depression and Anxiety. 8: 131-3. PMID 9836065 DOI: 10.1002/(SICI)1520-6394(1998)8:3<131::AID-DA6>3.0.CO;2-G  0.8
1998 Pollack MH, Otto MW, Worthington JJ, Manfro GG, Wolkow R. Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial. Archives of General Psychiatry. 55: 1010-6. PMID 9819070 DOI: 10.1001/archpsyc.55.11.1010  0.92
1997 Wilhelm S, Otto MW, Zucker BG, Pollack MH. Prevalence of body dysmorphic disorder in patients with anxiety disorders. Journal of Anxiety Disorders. 11: 499-502. PMID 9407269  0.8
1997 McNally RJ, Hornig CD, Otto MW, Pollack MH. Selective encoding of threat in panic disorder: application of a dual priming paradigm. Behaviour Research and Therapy. 35: 543-9. PMID 9159978 DOI: 10.1016/S0005-7967(96)00125-8  0.8
1997 Worthington JJ, Pollack MH, Otto MW, Gould RA, Sabatino SA, Goldman L, Rosenbaum JF, Lee TH. Panic disorder in emergency ward patients with chest pain. The Journal of Nervous and Mental Disease. 185: 274-6. PMID 9114814 DOI: 10.1097/00005053-199704000-00009  0.92
1997 Gould RA, Otto MW, Pollack MH, Yap L. Cognitive behavioral and pharmacological treatment of generalized anxiety disorder: A preliminary meta-analysis Behavior Therapy. 28: 285-305. DOI: 10.1016/S0005-7894(97)80048-2  0.92
1996 Manfro GG, Otto MW, McArdle ET, Worthington JJ, Rosenbaum JF, Pollack MH. Relationship of antecedent stressful life events to childhood and family history of anxiety and the course of panic disorder. Journal of Affective Disorders. 41: 135-9. PMID 8961041 DOI: 10.1016/S0165-0327(96)00081-X  0.92
1996 Bruder GE, Otto MW, McGrath PJ, Stewart JW, Fava M, Rosenbaum JF, Quitkin FM. Dichotic listening before and after fluoxetine treatment for major depression: Relations of laterality to therapeutic response Neuropsychopharmacology. 15: 171-179. PMID 8840353 DOI: 10.1016/0893-133X(95)00180-L  0.92
1996 Gould RA, Ball S, Kaspi SP, Otto MW, Pollack MH, Shekhar A, Fava M. Prevalence and correlates of anger attacks: a two site study. Journal of Affective Disorders. 39: 31-8. PMID 8835651 DOI: 10.1016/0165-0327(96)00017-1  0.92
1996 Pollack MH, Otto MW, Sabatino S, Majcher D, Worthington JJ, McArdle ET, Rosenbaum JF. Relationship of childhood anxiety to adult panic disorder: correlates and influence on course. The American Journal of Psychiatry. 153: 376-81. PMID 8610825 DOI: 10.1176/ajp.153.3.376  0.92
1996 Pollack MH, Kradin R, Otto MW, Worthington J, Gould R, Sabatino SA, Rosenbaum JF. Prevalence of panic in patients referred for pulmonary function testing at a major medical center. The American Journal of Psychiatry. 153: 110-3. PMID 8540567 DOI: 10.1176/AJP.153.1.110  0.92
1996 Otto MW, Pollack MH, Sabatino SA. Maintenance of remission following cognitive behavior therapy for panic disorder: Possible deleterious effects of concurrent medication treatment Behavior Therapy. 27: 473-482. DOI: 10.1016/S0005-7894(96)80028-1  0.92
1994 Otto MW, Bruder GE, Fava M, Delis DC, Quitkin FM, Rosenbaum JF. Norms for depressed patients for the California verbal learning test: associations with depression severity and self-report of cognitive difficulties. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 9: 81-8. PMID 14589514 DOI: 10.1016/0887-6177(94)90016-7  0.92
1994 Otto MW, Pollack MH, Rosenbaum JF, Sachs GS, Asher RH. Childhood history of anxiety in adults with panic disorder: association with anxiety sensitivity and comorbidity. Harvard Review of Psychiatry. 1: 288-93. PMID 9384860 DOI: 10.3109/10673229409017091  0.8
1994 Pollack MH, Otto MW, Sachs GS, Leon A, Shear MK, Deltito JA, Keller MB, Rosenbaum JF. Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo. Journal of Affective Disorders. 30: 273-81. PMID 8014326 DOI: 10.1016/0165-0327(94)90134-1  0.8
1994 Otto MW, McNally RJ, Pollack MH, Chen E, Rosenbaum JF. Hemispheric laterality and memory bias for threat in anxiety disorders. Journal of Abnormal Psychology. 103: 828-31. PMID 7822587 DOI: 10.1037/0021-843X.103.4.828  0.8
1993 Otto MW, Yeo RA. Hemispheric activation, affective judgments, and pain perception. Psychotherapy and Psychosomatics. 60: 186-94. PMID 8272477 DOI: 10.1159/000288692  0.92
1992 Fouty HE, Otto MW, Yeo RA, Briggs CR. A novel contact-lens system to assess visual hemispheric asymmetries. Perceptual and Motor Skills. 74: 567-75. PMID 1594418 DOI: 10.2466/pms.1992.74.2.567  0.92
1991 Otto MW, Fava M, Rosenbaum JF, Murphy CF. Perceptual asymmetry, plasma cortisol, and response to treatment in depressed outpatients. Biological Psychiatry. 30: 703-10. PMID 1958767 DOI: 10.1016/0006-3223(91)90015-E  0.44
1989 Otto MW, Dougher MJ, Yeo RA. Depression, pain, and hemispheric activation. The Journal of Nervous and Mental Disease. 177: 210-8. PMID 2703826  0.92
1989 Falk WE, Rosenbaum JF, Otto MW, Zusky PM, Weilburg JB, Nixon RA. Fluoxetine versus trazodone in depressed geriatric patients. Journal of Geriatric Psychiatry and Neurology. 2: 208-14. PMID 2699556 DOI: 10.1177/089198878900200407  0.92
1987 Otto MW, Yeo RA, Dougher MJ. Right hemisphere involvement in depression: toward a neuropsychological theory of negative affective experiences. Biological Psychiatry. 22: 1201-15. PMID 3663775 DOI: 10.1016/0006-3223(87)90028-X  0.92
1985 Gluck JP, Otto MW, Beauchamp AJ. Respondent Conditioning of Self-Injurious Behavior in Early Socially Deprived Rhesus Monkeys (Macaca mulatta) Journal of Abnormal Psychology. 94: 222-226. PMID 4039737 DOI: 10.1037/0021-843X.94.2.222  0.92
Show low-probability matches.